GAMMA Investing’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-824
Closed -$14.8K 3924
2025
Q1
$14.8K Buy
824
+34
+4% +$604 ﹤0.01% 2555
2024
Q4
$13.8K Buy
790
+369
+88% +$4.99K ﹤0.01% 2455
2024
Q3
$4.85K Buy
421
+150
+55% +$1.72K ﹤0.01% 2758
2024
Q2
$3.07K Buy
271
+38
+16% +$506 ﹤0.01% 2743
2024
Q1
$3.34K Sell
233
-53
-19% -$751 ﹤0.01% 2566
2023
Q4
$4.18K Buy
+286
New +$3.01K ﹤0.01% 2320

GAMMA Investing's PTVE Position: Q2 2025 in Review

GAMMA Investing sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 824 shares — an estimated $14.8K sold.

GAMMA Investing first reported a position in PTVE in Q4 2023 and held it in 6 quarters. The position peaked at $14.8K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • GAMMA Investing reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • GAMMA Investing sold 824 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $14.8K.
  • GAMMA Investing first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2023 and held it in 6 quarters.
  • GAMMA Investing's Pactiv Evergreen Inc. Common stock position peaked at $14.8K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.